HopeStage
Back to all studies
CompletedNCT00350883

Cognitive therapy for negative symptoms and daily functioning in schizophrenia

About this titleRead the official source — NCT00350883
Behavioural studyAges 18–65United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
PhiladelphiaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateJuly 2006
Recruitment status
Completed
Enrollment listed in the registry
61
Sponsor
University of Pennsylvania
Sponsor type
University
Study type
Behavioral
Intervention type
Behavioural, Other
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT00350883
Official title
Show the full official title

Cognitive Therapy for Negative Symptoms and Functioning

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Pennsylvania, a university.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies